KLDO - Kaleido Biosciences - Stock Forecast

Healthcare - Sector
Coverage Performance Price Targets & Ratings Chart Insider Trading

KLDO is currently covered by 1 analysts with an average price target of $3.01. This is a potential upside of $3.01 (0%) from yesterday's end of day stock price of $0.

Kaleido Biosciences's activity chart (see below) currently has 15 price targets and 11 ratings on display. The stock rating distribution of KLDO is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 35.4 days.

Highest price target for KLDO is $2, Lowest price target is $2, average price target is $3.01.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 04-Apr-2022. First documented stock forecast 25-Mar-2019.

Best performing analysts who are covering KLDO - Kaleido Biosciences:

Matthew Harrison Keay Nakae Edward Tenthoff Jessica Fye Gobind Singh

Currently out of the existing stock ratings of KLDO, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

1.7

$1.7 (0.00%)

3

2 years 21 days ago

0/3 (0%)

$0.06 (3.66%)

Buy

4

$4 (0.00%)

19

2 years 2 months 28 days ago

0/2 (0%)

$2.26 (129.89%)

Buy

22

$22 (0.00%)

22

2 years 5 months 22 days ago

0/2 (0%)

$14.82 (247.54%)

Sell

3

$3 (0.00%)

8

2 years 6 months 5 days ago

6/6 (100%)

$-1.56 (-34.21%)

78

Sell

5

$5 (0.00%)

10

2 years 10 months 9 days ago

2/2 (100%)

$-0.55 (-9.42%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KLDO (Kaleido Biosciences) average time for price targets to be met?

On average it took 35.4 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on KLDO (Kaleido Biosciences) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on KLDO (Kaleido Biosciences) with a proven track record?

GOBIND SINGH

Which analyst has the most public recommendations on KLDO (Kaleido Biosciences)?

Matthew Harrison works at MORGAN STANLEY and has 38 price targets and 16 ratings on KLDO

Which analyst is the currently most bullish on KLDO (Kaleido Biosciences)?

Gobind Singh with highest potential upside - $22

Which analyst is the currently most reserved on KLDO (Kaleido Biosciences)?

Keay Nakae with lowest potential downside - $1.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?